Mina Sooch
2021 - Rexahn Pharmaceuticals
In 2021, Mina Sooch earned a total compensation of $801K as Chief Executive Officer and President at Rexahn Pharmaceuticals, a 66% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $246,750 |
|---|---|
| Salary | $525,000 |
| Other | $29,280 |
| Total | $801,030 |
Sooch received $525K in salary, accounting for 66% of the total pay in 2021.
Sooch also received $246.8K in non-equity incentive plan and $29.3K in other compensation.
Rankings
In 2021, Mina Sooch's compensation ranked 9,474th out of 12,415 executives tracked by ExecPay. In other words, Sooch earned more than 23.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,474 out of 12,415 | 24th |
Division Manufacturing | 4,198 out of 5,505 | 24th |
Major group Chemicals And Allied Products | 1,858 out of 2,375 | 22nd |
Industry group Drugs | 1,648 out of 2,096 | 21st |
Industry Pharmaceutical Preparations | 1,225 out of 1,546 | 21st |
Source: SEC filing on April 27, 2022.
Sooch's colleagues
We found two more compensation records of executives who worked with Mina Sooch at Rexahn Pharmaceuticals in 2021.